Semaglutide: Treat-to-Target approach improves cardiovascular profile
19/11/2025
Introduction Recent advances in pharmacotherapy for obesity have shown that the magnitude of weight loss is not the only relevant
Aprobación de un nuevo parche de terapia hormonal genérico Recentemente, la FDA aprobó el primer genérico del sistema transdérmico de…
Read more →Introduction Recent advances in pharmacotherapy for obesity have shown that the magnitude of weight loss is not the only relevant
